ES8600692A1 - Procedimiento de producir antigenos y sus intermedios - Google Patents

Procedimiento de producir antigenos y sus intermedios

Info

Publication number
ES8600692A1
ES8600692A1 ES526622A ES526622A ES8600692A1 ES 8600692 A1 ES8600692 A1 ES 8600692A1 ES 526622 A ES526622 A ES 526622A ES 526622 A ES526622 A ES 526622A ES 8600692 A1 ES8600692 A1 ES 8600692A1
Authority
ES
Spain
Prior art keywords
same
related antigen
binding
glycosidic linkage
thermally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES526622A
Other languages
English (en)
Other versions
ES526622A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57177411A external-priority patent/JPS5967224A/ja
Priority claimed from JP58100528A external-priority patent/JPS59225119A/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of ES526622A0 publication Critical patent/ES526622A0/es
Publication of ES8600692A1 publication Critical patent/ES8600692A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/001102Receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA LA PRODUCCION DE ANTIGENOS, EN PARTICULAR, PARA PRODUCIR UN ANTIGENO RELACIONADO CON LA UNION O ENLACE GLICOSIDICO, DESNATURALIZADO TERMICAMENTE.COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE SEPARA UNA GLICOPROTEINA QUE TIENE UNA ESTRUCTURA TERMINAL SACARIDICA DE GALACTOSA O N-ACETILGALACTOSAMINA, DE UN COMPONENTE DE MEMBRANA DE CELULAS DE CANCER, DICHA SEPARACION SE REALIZA TRATANDO EL COMPONENTE DE MEMBRANA DE CELULA CON UNA LECTINA QUE PUEDE COMBINARSE CON UNA GALACTOSA TERMINAL; SEGUNDA, SE AISLA LA GLICOPROTEINA ENLAZADA A LA LECTINA; Y POR ULTIMO, SE CALIENTA LA GLICOPROTEINA DE TAL MANERA QUE LA PORCION DE PROTEINA SE DESNATURALICE, PERO NO LA PORCION DE SACARIDO.DE APLICACION EN EL TRATAMIENTO DEL CANCER.
ES526622A 1982-10-08 1983-10-07 Procedimiento de producir antigenos y sus intermedios Expired ES8600692A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57177411A JPS5967224A (ja) 1982-10-08 1982-10-08 糖鎖関連抗原およびその製造法ならびにこれを有効成分とする抗癌剤
JP58100528A JPS59225119A (ja) 1983-06-06 1983-06-06 熱変性抗原の製造法

Publications (2)

Publication Number Publication Date
ES526622A0 ES526622A0 (es) 1985-11-01
ES8600692A1 true ES8600692A1 (es) 1985-11-01

Family

ID=26441535

Family Applications (2)

Application Number Title Priority Date Filing Date
ES526622A Expired ES8600692A1 (es) 1982-10-08 1983-10-07 Procedimiento de producir antigenos y sus intermedios
ES544306A Expired ES8700056A1 (es) 1982-10-08 1985-05-30 Procedimiento de producir antigenos relacionados con el enlace glicosidico derivados de cancer.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES544306A Expired ES8700056A1 (es) 1982-10-08 1985-05-30 Procedimiento de producir antigenos relacionados con el enlace glicosidico derivados de cancer.

Country Status (8)

Country Link
EP (1) EP0106285A3 (es)
CA (1) CA1236016A (es)
DK (1) DK463283A (es)
ES (2) ES8600692A1 (es)
FI (1) FI80711C (es)
NO (1) NO833655L (es)
PH (1) PH23701A (es)
PT (1) PT77472B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法
SE468231B (sv) * 1984-05-18 1992-11-23 Kabi Pharmacia Ab Foerfarande foer att paavisa smaacelligt lungcarcinomantigen och anvaendning av antikroppar mot fukosylsialosylgangliotetraos foer framstaellning av komposition foer behandling eller in vivo/ diagnos
JPH03263401A (ja) * 1990-03-13 1991-11-22 Nippon Koutai Kenkyusho:Kk 新規糖鎖
MD838G2 (ro) * 1992-07-21 1998-09-30 Alexandr Nicolaenco Remediu biologic activ cu proprietate imunomodulatoare, procedeu de obţinere a lui, preparat pe baza lui şi procedeu de normalizare a stării fiziologice a omului şi animalelor
US5376531A (en) * 1992-09-03 1994-12-27 Northwestern University Method of detecting cancer
DK140992D0 (da) * 1992-11-24 1992-11-24 Ole Buchardt Fremgangsmaade til frembringelse af antistoffer mod haptener og andre b-celle-antigener, antistoffer opnaaet ved fremgangsmaaden og anvendelse af disse antistoffer til fremstilling af vacciner, isaer til veterinaermedicinsk brug

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3152851A1 (de) * 1981-05-19 1983-05-19 Stephen Sugaar Stark antigene tumorspezifische stoffe und verfahren zum nachweis von krebs unter verwendung dieser stoffe
GB2106935B (en) * 1981-10-01 1985-01-30 Otsuka Pharma Co Ltd Cancer cell-combatting lymphocytes process for the production thereof and anticancer agents containing said lymphocytes
NO830570L (no) * 1982-02-22 1983-08-23 Carlton Med Prod Antistoffer og antigener for diagnose og behandling av cancer

Also Published As

Publication number Publication date
NO833655L (no) 1984-04-09
ES8700056A1 (es) 1986-10-16
EP0106285A2 (en) 1984-04-25
PH23701A (en) 1989-09-27
FI833652A0 (fi) 1983-10-07
PT77472B (en) 1986-02-12
ES526622A0 (es) 1985-11-01
PT77472A (en) 1983-11-01
FI80711B (fi) 1990-03-30
FI833652A (fi) 1984-04-09
DK463283A (da) 1984-04-09
FI80711C (fi) 1990-07-10
ES544306A0 (es) 1986-10-16
DK463283D0 (da) 1983-10-07
EP0106285A3 (en) 1987-09-02
CA1236016A (en) 1988-05-03

Similar Documents

Publication Publication Date Title
BR1100843A (pt) Mak 195, linha celular hìbrida, processo de preparação de anticorpos monoclonais mak 195, aplicação do anticorpo monoclonal mak 195
IE830531L (en) Enzyme-antibody conjugates associated by covalent bond
AU3777989A (en) Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
NZ237666A (en) Hiv envelope (env) polypeptides, antibodies and compositions for treating aids
GR3036951T3 (en) Cells with multiple altered epitopes on a surface antigen for use in transplantation
IL115373A0 (en) Antigen binding peptides (abtides) from peptide libraries
ES2176347T3 (es) Modulacion de la respuesta inmune.
WO1999058678A3 (en) Antibodies to dendritic cells and human dendritic cell populations and uses thereof
ES8700056A1 (es) Procedimiento de producir antigenos relacionados con el enlace glicosidico derivados de cancer.
EP0270930A3 (en) Substantially pure enzyme-antibody conjugate preparations
EP0194158A3 (en) Anti-nicotine and anti-cotinine antibodies (monoclonal and other), and their uses in nicotine and cotinine assays
AU2911289A (en) Carcinoma-associated antigens, and antibodies which recognize these antigens
HK1041273A1 (en) Compositions and method for generating monoclonal antibodies representative of a specific cell type
KR850007431A (ko) 글리코사이드 결합 관련 항원의 제조방법
CA2101534A1 (en) Monoclonal antibodies to putative hcv envelope region and methods for using same
IE880701L (en) Immunoglobulin conjugates
EP0109861A3 (en) Method for isolating cells
Mark et al. B‐cell lymphoma marking only with anti‐epithelial. Membrane antigen
EP0306680A3 (en) Monoclonal antibodies to anti-thrombin binding substance, and their uses
WO1987007302A3 (en) MONOCLONAL ANTIBODIES TO HUMAN LYMPHOCYTE IgE RECEPTORS, HYBRIDOMAS PRODUCING SUCH ANTIBODIES, AND KITS FOR USING SUCH ANTIBODIES
AU2900184A (en) Membrane antigens generated from pooled cells and monoclonal antibodies
KR840006439A (ko) 글리코사이드 결합된 항원의 제조방법
AU556941B2 (en) Glycosidic linkage related antigen
Baldwin et al. Monoclonal Antibodies Specifying Antigens Associated with Rat Tumors and Their Use in Drug Delivery Systems
NO882518D0 (no) Fremgangsmaater ved forbedret binding til antistoff, antistoff-fragmenter, hormoner og andre bindingsmidler, og konjugater derav.